top of page

DIABETES THERAPEUTIC SOLUTIONS
For a Life Free of Insulin


S100A9 protein: an alternative solution to Type 1 Diabetes (T1D) therapy
A new approach to make current insulin therapy safer and more effective
Recombinant S100A9 protein is an adjuvant to insulin in the therapy of T1D patients with inadequate
glycemic control

Diatheris
Dr. Giorgio Ramadori, PhD
-
UNIGE Faculty of Medicine
-
Extensive preclinical research experience in diabetes
​
Prof. Roberto Coppari, PhD
-
UNIGE Faculty of Medicine
-
Head of Diabetes Center
-
20 years diabetes research experience

bottom of page